On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini. This instrumentation change is necessary as Bio-Rad is discontinuing service on our existing QuickStep instrumentation.
Although the Immucor assay and sample requirements will remain the same, the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list will be available on the CTS website on 04/29/19.
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...